Doctors Note Logo

Published on: 4/21/2026

Horizant (Gabapentin Enacarbil): A New Option for Nerve Relief

Horizant (gabapentin enacarbil) is an extended release form of gabapentin approved for restless legs syndrome and postherpetic neuralgia that shows promise as a once daily treatment for diabetic peripheral neuropathy by providing steadier blood levels to reduce burning, tingling and nighttime flare ups. Early evidence suggests it may improve sleep quality and daily function compared with multiple daily doses of immediate release gabapentin.

Important information on dosing schedules, side effects, safety considerations and comparisons with other therapies can be found below and may influence your next steps in managing diabetic nerve pain.

answer background

Explanation

Horizant (Gabapentin Enacarbil): A New Option for Nerve Relief

Diabetic peripheral neuropathy (DPN) can cause burning, tingling or stabbing pain in the hands and feet. Many people with diabetes find their daily lives impacted by nerve pain that disrupts sleep, walking and mood. Horizant (gabapentin enacarbil) is an extended-release form of gabapentin approved by the FDA to manage moderate to severe restless legs syndrome and postherpetic neuralgia. Emerging evidence suggests it may also help ease diabetic nerve pain. Below, we'll explore how Horizant works, its potential benefits and important safety considerations for using Horizant for diabetic pain.


Understanding Diabetic Nerve Pain

Diabetic peripheral neuropathy arises when high blood sugar levels damage small nerve fibers. Common symptoms include:

  • Burning or searing pain in the feet, calves, hands or arms
  • Numbness or tingling that worsens at night
  • Increased sensitivity to touch or temperature
  • Muscle weakness or coordination problems over time

Left untreated, DPN can interfere with daily activities, sleep quality and overall well-being. Early recognition and treatment are key to preventing complications such as foot ulcers.


What Is Horizant?

Horizant contains gabapentin enacarbil, a prodrug converted into gabapentin after absorption. Its extended-release design aims for:

  • More consistent blood levels over 12-hour dosing
  • Reduced peaks and troughs compared with immediate-release gabapentin
  • Potentially fewer doses per day, simplifying routines

Originally studied for restless legs syndrome, researchers have explored Horizant's role in other neuropathic pain conditions, including diabetic nerve pain.


How Horizant Works for Diabetic Pain

Gabapentin modulates calcium channels on nerve cells. By reducing excessive electrical activity in damaged nerves, it can:

  • Decrease spontaneous nerve firing that causes burning or shooting pain
  • Lessen central sensitization—when the spinal cord and brain overreact to normal stimuli
  • Improve overall pain thresholds and quality of life

Horizant's extended-release formulation helps maintain stable gabapentin levels, which may translate into smoother pain relief for those using Horizant for diabetic pain.


Evidence for Horizant in Diabetic Neuropathy

While gabapentin immediate release is widely prescribed off-label for DPN, specific trials of gabapentin enacarbil are more limited. Key findings include:

  • A phase II clinical study reported significant pain reduction in DPN patients taking gabapentin enacarbil versus placebo.
  • Patient‐reported improvements in sleep quality and nightly pain scores with extended‐release gabapentin formulas.
  • Comparisons to pregabalin (another gabapentinoid) suggest similar effectiveness but varying side-effect profiles.

Overall, Horizant shows promise as an alternative to immediate-release formulations, especially for patients seeking once‐ or twice‐daily dosing.


Benefits of Using Horizant for Diabetic Pain

  1. Convenient Dosing

    • Taken once daily at 5 pm to target nighttime symptoms
    • Extended‐release design avoids multiple daytime doses
  2. Consistent Pain Control

    • Steady gabapentin levels may reduce breakthrough pain
    • Can improve sleep by minimizing nighttime flare-ups
  3. Well-Studied Mechanism

    • Gabapentin's safety and efficacy in neuropathic pain are well documented
    • FDA‐approved for related nerve pain conditions
  4. Potential Quality-of-Life Gains

    • Reduced pain can enhance mobility, mood and overall function
    • May decrease reliance on opioids or other sedating analgesics

Common Side Effects & Safety Considerations

As with any medication, Horizant carries potential risks. The most frequent side effects include:

  • Dizziness or lightheadedness
  • Sleepiness or fatigue
  • Swelling in ankles or feet (peripheral edema)
  • Weight gain

Less common but serious warnings:

  • Respiratory depression, especially in patients with lung disease or taking opioids
  • Suicidal thoughts or mood changes—monitor mental health
  • Hypersensitivity reactions (rash, swelling, difficulty breathing)

Tips to improve safety:

  • Start at the lowest recommended dose and titrate slowly under medical guidance
  • Avoid alcohol and other sedating substances
  • Monitor for mood changes and report concerns promptly

Always discuss your full medical history—including kidney function, respiratory status and current medications—with your doctor before starting Horizant.


Dosage & Administration

A typical dosing schedule for Horizant when used off-label for diabetic neuropathy may mirror approved uses:

  1. Begin with 300 mg once daily at 5 pm for 3 days.
  2. Increase to 600 mg once daily at 5 pm, as tolerated.
  3. Maximum dose usually does not exceed 600 mg twice daily (1,200 mg total).

Your healthcare provider will tailor the dose based on:

  • Pain severity and symptom pattern
  • Kidney function (adjustments needed for reduced clearance)
  • Tolerance of side effects

Never split, crush or chew the tablets—swallow them whole to preserve the extended-release properties.


Comparing Horizant to Other Treatments

Horizant for diabetic pain offers an alternative to several common options:

  • Tricyclic antidepressants (e.g., nortriptyline): effective but may cause dry mouth, constipation and heart rhythm issues.
  • Serotonin-norepinephrine reuptake inhibitors (e.g., duloxetine): helpful, especially with concurrent depression or anxiety.
  • Pregabalin: similar mechanism; requires multiple daily doses in some cases.
  • Opioids: effective but carry high risk of dependence, sedation and constipation.

Choosing the right therapy involves balancing efficacy, side effects, dosing convenience and personal health goals.


Who Might Benefit Most?

Horizant for diabetic pain may be suited to patients who:

  • Experience moderate to severe DPN pain interfering with sleep or daily function
  • Have struggled with multiple daily doses of other gabapentinoids
  • Seek a non-opioid option with proven nerve pain efficacy
  • Are willing to monitor side effects like drowsiness and edema

It's not recommended for pregnant or breastfeeding individuals, those with significant respiratory disease, or patients with severe kidney impairment without dose adjustments.


Practical Tips for Success

  • Take Horizant at the same time each evening (around 5 pm).
  • Keep a pain diary: note intensity, duration and side effects.
  • Stay hydrated and maintain a balanced diet to help manage weight changes.
  • Wear compression socks if mild swelling occurs.
  • Engage in gentle exercise (walking, stretching) to support circulation.
  • Practice good foot care to prevent wounds and ulcers.

Checking Your Symptoms

If you're experiencing burning, tingling or numbness and want to understand what might be causing your discomfort, Ubie's Medically approved LLM Symptom Checker Chat Bot can help you identify potential conditions and determine whether you should seek professional care—it's free, quick and available 24/7.


When to Speak to a Doctor

Always consult your healthcare provider before starting, stopping or changing any medication. Seek immediate medical attention if you experience:

  • Signs of allergic reaction: hives, swelling of face/lips, breathing difficulty
  • Severe dizziness, fainting or confusion
  • New or worsening mood changes, suicidal thoughts
  • Difficulty breathing, especially when combined with other sedatives

For ongoing diabetic pain, work closely with your doctor to develop a comprehensive plan that may include blood sugar control, lifestyle measures and medication like Horizant.


Conclusion

Horizant (gabapentin enacarbil) offers a promising once-daily option for people suffering from diabetic peripheral neuropathy. Its extended-release formula can provide steadier pain relief, improved sleep and a potential reduction in the need for multiple daily doses. By understanding its benefits, risks and proper use, you can make an informed decision about whether Horizant for diabetic pain could fit into your treatment plan. Always discuss any serious or life-threatening concerns with your doctor. With the right approach, relief from diabetic nerve pain is within reach.

(References)

  • * Schwartz SL, Versavel M, Johnson P, et al. Gabapentin enacarbil in the treatment of postherpetic neuralgia: a phase 3, randomized, double-blind, placebo-controlled trial. *J Pain*. 2013 Aug;14(8):844-55. doi: 10.1016/j.jpain.2013.02.007. Epub 2013 Apr 20. PMID: 23740266.

  • * Chen C, Gu D, Liu H, Wang J. Gabapentin enacarbil extended-release for the treatment of moderate-to-severe primary restless legs syndrome: A meta-analysis. *J Clin Pharm Ther*. 2018 Dec;43(6):793-802. doi: 10.1111/jcpt.12720. Epub 2018 Jun 18. PMID: 29916174.

  • * Zuniga J, Laux L, Sisk CM, Bieszk N, Pleshko AM. Gabapentin enacarbil extended-release for treatment of postherpetic neuralgia: a review of efficacy, safety, and patient selection. *Pain Ther*. 2013 Dec;2(2):101-14. doi: 10.1007/s40122-013-0017-8. Epub 2013 Aug 31. PMID: 24204558; PMCID: PMC3931693.

  • * Zhu Y, Yang B, Feng Y, et al. Efficacy and Safety of Gabapentin Enacarbil for the Treatment of Primary Restless Legs Syndrome: A Systematic Review and Meta-Analysis. *Neurol Ther*. 2021 Jun;10(3):1219-1234. doi: 10.1007/s40120-021-00262-1. Epub 2021 May 29. PMID: 34050962; PMCID: PMC8164082.

  • * Wang M, Peng X, Lv J, Liu Y. Gabapentin enacarbil for the treatment of postherpetic neuralgia: a meta-analysis of randomized placebo-controlled trials. *Pain Physician*. 2014 Mar-Apr;17(2):E161-8. PMID: 24658485.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.